Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling-Reference-Cited by-同舟云学术

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling

Published:2018-07-16 Issue:22 Volume:24 Page:5697-5709
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

González-González Adrián,Muñoz-Muela Esperanza,Marchal Juan A.^ORCID,Cara Francisca E.,Molina Maria P.^ORCID,Cruz-Lozano Marina,Jiménez Gema,Verma Akanksha,Ramírez Alberto,Qian Wei,Chen Wen,Kozielski Anthony J.,Elemento Olivier,Martín-Salvago María D.,Luque Rafael J.^ORCID,Rosa-Garrido Carmen,Landeira David,Quintana-Romero María^ORCID,Rosato Roberto R.,García Maria A.,Ramirez-Tortosa Cesar L.,Kim Hanna,Rodriguez-Aguayo Cristian^ORCID,Lopez-Berestein Gabriel,Sood Anil K.,Lorente Jose A.^ORCID,Sánchez-Rovira Pedro,Chang Jenny C.,Granados-Principal Sergio

Funder

Institute of Health Carlos III

Ministry of Economy and CompetitivenessMinistry of Health, Andalusian Regional GovernmentMinistry of Health, Andalusian Regional Government

Andalusian Regional Government and University of Granada

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions;Pharmacological Research;2024-10

2. A bird’s eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications;Cell Death & Disease;2024-09-11

3. ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer;Pathobiology;2024-06-11

4. ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer;Scientific Reports;2024-06-06

5. Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy;Molecular Cancer;2024-05-09